BCX7353
BCX7353-202
Phase 2 small_molecule completed
Quick answer
BCX7353 for Hereditary Angioedema (HAE) is a Phase 2 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Hereditary Angioedema (HAE)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed